,CBL:

Liu Liu1, Yan Zhu2, Jingjing Lan3

  • 1The Second Affiliated Hospital of Guangxi Medical University, Department of Nephrology, Nanning Guangxi, 530007, China; The First Affiliated Hospital, Department of Nephrology, Hengyang Medical School, University of South China, Hengyang Hunan, 421001, China.

Cytokine
|April 26, 2024
PubMed
概括

卡西塔斯B系淋巴瘤 (CBL) 基因的遗传变异可能会影响中国人群中的微观多炎 (MPA) 风险和治疗结果. 特定的CBL单核酸多态 (SNPs) 显示出对MPA的保护作用,并与更好的临床反应相关.